DNA methylation, one of the best-studied epigenetic marks in eukaryotes, is a biological process in which a methyl group is covalently added to a cytosine, yielding 5-methylcytosine (5mC) [1] [2] [3] 
. The evolutionary conservation of these enzymes suggests that DNA methylation provides a selective advantage to the organism. However, the percentage of methylated cytosine varies substantially across species. For example, vertebrates and plants often have a high percentage of methylated CpG dinucleotides outside CpG islands, whereas invertebrates typically exhibit intermediate levels or no methylation 7, 8 . With the development of more sensitive methodological approaches, such as methylated DNA immunoprecipitation followed by bisulfite sequencing (MeDIP-BS-seq) -which sequences bisulfite-converted DNA species after enrichment for methylated DNA fragments using an anti-5mC antibody -some genomes previously considered not to have any DNA methylation (for example, that of Drosophila melanogaster) have now been found to be methylated at a limited number of cytosines [9] [10] [11] . In most animals, DNA is methylated predominantly at CpG dinucleotides, whereas in plants and fungi, a large fraction of DNA methylation also occurs at CHG or CHH (where H can be any nucleotide but G) [12] [13] [14] [15] . That said, it was recently discovered that a small fraction of non-CpG methylation also occurs in animals
.
DNA methylation has a critical role as a means to control gene expression; for example, during development to ensure X-chromosome inactivation or genomic imprinting 16, 17 through various mechanisms. Furthermore, aberrant DNA methylation is a hallmark of many diseases, including various types of cancers 18 . Indeed, abnormal gains in methylation in normally unmethylated CpG islands have been linked to the inactivation of tumour suppressor genes [19] [20] [21] . Such abnormal promoter CpG island methylation is emerging as a potential biomarker for cancer detection, diagnosis and prognosis 22, 23 . More recently, DNA methylation has also been implicated in non-cancerous diseases, such as schizophrenia 24 and autism spectrum disorders 25, 26 . Thanks to rapid technological advances, especially the range of techniques based on deep sequencing, it is now possible to monitor the dynamics of the DNA methylome at single-nucleotide resolution [27] [28] [29] . These developments have provided new insights into how the epigenome is shaped and how it regulates different biological processes, such as cellular differentiation and cancer development. For instance, comparing methylation profiles under different physiological conditions revealed tissue-specific or disease-specific differentially . Several lines of evidence suggest that non-CpG methylation might be functional. First, the flanking sequences of the methylated CpH (mCpH) showed similar motifs to 5′-TNCA(C/G) 125 (where N can be any nucleotide). Second, the position of DNA methylation is highly conserved across different cell types 27 . Third, gene expression level is negatively correlated with the methylation level in the gene body 125 . To understand the biological functions of the modification, identification of the proteins that interact with these modifications would be a crucial step.
One such protein is methyl-CpG-binding protein 2 (MeCP2), which is known to interact with mCpG sites and negatively regulates gene expression. Superimposing MeCP2 chromatin immunoprecipitation followed by sequencing (ChIP-seq) and mCpH profiles in neurons showed an enrichment of mCpH around the binding peak of MeCP2. MeCP2 ChIP followed by bisulfite sequencing (ChIP-BS-seq) confirmed its ability to bind mCpH sites in vivo 124 . In vitro electrophoretic mobility shift assays (EMSAs) demonstrated a direct interaction between MeCP2 and mCpH. The relative affinity of MeCP2 with mCpA is similar to that with mCpG 126, 127 . However, the affinity of MeCP2 for mCpT and mCpC is markedly lower than for mCpA and mCpG 126, 127 .
Methylcytosine derivatives
It is well known that DNA methyltransferases (DNMTs) are the enzymes responsible for cytosine methylation, although it long remained elusive which enzymes could reverse DNA methylation in metazoans. In 2009, it was discovered that DNA demethylation might be a multistep process that involves TET (ten-eleven translocation) methylcytosine dioxygenase enzymes that convert 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) 128, 129 (see the figure) . These enzymes can further oxidize 5hmC to 5-formylcytosine (5fC) and to 5-carboxylcytosine (5caC) 130, 131 . Thymine-DNA glycosylase (TDG)-mediated base excision repair (BER) of 5fC and 5caC can regenerate unmethylated cytosines 132, 133 . One important question is whether these oxidized derivatives of 5mC are simply the intermediate products of the demethylation process, or whether they have a functional role themselves. Genome-wide sequencing approaches have generated 5hmC, 5fC and 5caC profiles and have revealed the distribution of these modifications across the genome 130, 131, [134] [135] [136] [137] . The modification levels for these three derivatives are substantially lower than the mCpG levels. For example, the level of 5hmC (that is, 5hmCG/CG) varies from 1% to 30% depending on the cell type 27, 134, 135, 138 , whereas the levels of 5fC and 5caC range from 8% to 10% (REFS 139, 140) . In comparison, the methylation level for mCpG typically ranges from 80% to 90% (REF. 28 ).
These modifications are not randomly distributed in the genome, but show a preference for certain genomic regions. For example, 5hmC is enriched at distal regulatory elements, such as enhancers and DNase I hypersensitivity sites 134 , 5fC is enriched in poised enhancers 137 and a large fraction of 5fC sites are located in intragenic regions with a particular enrichment in exons 141 . By contrast, 5caC was found to be preferentially enriched at major satellite repeats 136 . Interestingly, different modifications showed distinct patterns surrounding protein-DNA binding sites 135 .
To understand the function of these modifications, researchers have started to identify proteins that interact with these modifications using various techniques, including mass spectrometry-based approaches 51, 142 . For example, MeCP2 was recently found to bind to 5hmC 127, [143] [144] [145] , and the binding affinity seems to be context-dependent. The binding of MeCP2 to 5hmCG, 5hmCC and 5hmCT is substantially weaker than their corresponding methylated probes. However, the conversion of mCpA to 5hmCA does not alter the high affinity binding to MeCP2 (REFS 127, (143) (144) (145) . Interestingly, the binding of these readers is often modification-specific and cell type-specific 51, 142 . For example, THAP domain-containing protein 11 (THA11), a transcriptional repressor that plays a central part in embryogenesis, was identified as a brain-specific 5hmC reader 51 . In addition, a number of forkhead box proteins (FOXK1, FOXK2, FOXP1, FOXP4 and FOXI3) were found to interact with 5fC 142 . The dynamic nature of such interactions suggests specific and complex biological roles for these modifications. We expect that more proteins remain to be discovered because these studies only used one or two DNA probes, and because the binding of many proteins could depend on the sequence context surrounding the modifications. Nature Reviews | Genetics In this Analysis article, we review the discovery of a new class of methylated-DNA-binding proteins, namely transcription factors (TFs), and the approaches used to discover these interactions. We focus on the interaction partners with methylated CpG sites in mammals, with a brief discussion of other methylation derivatives
. We then summarize the specific properties of methylation-dependent interactions between TFs and DNA, and discuss the causal relationship between TF-DNA interactions and DNA methylation, before concluding with an overview of potential biological consequences of methylation-dependent protein-DNA interactions.
Readers of methylated DNA
The classical view of methylation-mediated protein-DNA interactions is that only proteins with a methylCpG (mCpG)-binding domain (MBD) can recognize and bind to methylated CpG dinucleotides 3, 6, [33] [34] [35] (FIG. 1) .
The MBD protein family has five known members in mammals, including MeCP2 (methyl-CpG-binding protein 2), MBD1, MBD2, MBD3 and MBD4. Except for MBD3, which does not bind to methylated DNA, all MBD proteins bind to methylated DNA in a nonsequence-specific manner 36, 37 . Comparison of MBD proteins from different species showed conservation and divergence in terms of the number of MBD genes and the composition of the MBD domains 6, 38 . Interestingly, the extent of genomic methylation generally correlates with the number of MBD proteins in a species 6 . Dysfunction of MBD proteins is associated with human diseases. For example, mutations in the gene encoding MeCP2 cause the neurodevelopmental disorder Rett syndrome 39, 40 . Over the past 15 years, evidence has emerged that suggests that some TFs lacking MBDs are able to interact with methylated DNA [23] [24] [25] [26] [27] (FIG. 1) . Unlike MBD proteins, a handful of mammalian TFs were found to possess sequence-dependent mCpG-binding activity in a few studies. For example, the transcriptional regulator Kaiso, which contains POZ (pox virus and zinc-finger) and zinc-finger domains, was found to bind to a specific methylated sequence with its C2H2 zinc-finger domains 41 . In other studies, the basic leucine zipper (bZIP) CCAAT/enhancer-binding protein-α (CEBPα) 42 , the zinc-finger protein ZFP57 and its cofactor KRAB-associated protein 1 (KAP1; also known as TIF1β) 43, 44 were shown to interact with specific methy lated sequences. In addition to mammalian proteins, a bZIP herpesvirus protein, Zta, was found to bind to methylated regulatory elements and control the epigenetic landscape during the latency-to-lytic phase transition in infected mammalian cells 45 . Two amino acids, one cysteine and one serine, were found to interact with 5mC 45 . In rice, the nuclear protein MVBP (methylated VBE-binding protein) was shown to bind to a rice tungro bacilliform virus promoter region only when the promoter was methylated 46 .
As the discovery of these mCpG-binding proteins was often serendipitous, whether TFs represent a new class of DNA methylation readers and, potentially, effectors, and whether sequence-specific mCpG-dependent binding activity is a widespread phenomenon or merely an exception, remained questionable. In addition, recent large-scale analyses of gene expression profiles and DNA methylomes showed that a substantial portion of DNA methylation sites is positively correlated with gene expression 31 . This finding may result from the high levels of DNA methylation in the gene body of highly expressed genes; however, it also raises the possibility that some TFs bind to methylated regulatory elements and activate gene expression. It should be noted that DNA methylation of a promoter or an enhancer has been shown to be correlated with increased transcription of a target gene [47] [48] [49] , although most of the evidence showing a positive correlation between methylation and expression seems to result from methylation downstream of the transcription start site. Intrigued by these observations, several research groups have conducted unbiased, high-throughput screens to search for such a correlation in higher eukaryotes (TABLE 1) .
High-throughput reader discovery Tandem mass spectrometry. One systematic approach for the discovery of mCpG-binding proteins is based on tandem mass spectrometry (MS/MS) 50, 51 . A recent study used a generic DNA sequence harbouring an mCpG site to pull down interacting proteins from nuclear extracts of cultured cells 51 . Proteins bound to methylated DNA sequences were then identified by MS/MS. Based on this approach, 19 proteins were identified that interact preferentially with the methylated DNA probe rather than the non-methylated counterpart in mouse embryonic stem (ES) cell nuclear extracts. Besides the known MBD proteins (such as MeCP2, MBD1 and MBD4), many TFs (such as MHC class II regulatory factor RFX1, zinc-finger homeobox 3 (ZFHX3), lysinespecific histone demethylase 1A (LSD1), zinc-finger and BTB domain-containing protein 44 (ZBT44) and thymo cyte nuclear protein 1 (THYN1; also known as THY28), and the Krüppel-like factors (for example, KLF2, KLF4 and KLF5)), were identified as new mCpGbinding proteins (TABLE 2) . The authors applied the same approach to neuronal progenitor cells and found that a large and distinct set of proteins showed preferential binding to mCpG sites, suggesting that the interaction with mCpG is dynamic and thus varies under different physiological conditions. A similar approach was also used to identify nucleosome-interacting proteins that are affected by DNA methylation 50 . Although proteins from cell extracts are in a more native state in the MS/MS-based approach, the DNA probes used in this approach are typically generic and, therefore, sequence specificity of observed interactions remains elusive.
Functional protein microarray. Functional protein microarrays have been used as a powerful tool to profile protein-DNA interactions in the past 52 . A comprehensive examination of sequence-specific mCpG-binding activities was conducted by sequentially probing a human protein microarray containing 1,321 TFs and 210 cofactors with 154 DNA motifs that each carried at least one mCpG site 53 . To identify human TFs that preferentially bind to methylated DNA motifs, each methylated motif was mixed with its unlabelled and unmethylated counterpart in tenfold excess in the binding assays. This competition assay ensures that the identified interactions are indeed methylationdependent, rather than due to CpG-flanking sequences. Of the 154 methylated motifs examined, 150 showed strong binding signals to at least one protein on the microarray. In total, 41 TFs and 6 cofactors were found to bind to at least one methylated sequence. Most of these factors were found to bind to only a few methylated sequences, suggesting that the interactions are not only methylation-dependent but also sequence-specific. Interestingly, the factors that showed binding activity to methylated sequences were widespread among various TF subfamilies, such as zf-C2H2, homeobox, bHLH (basic helix-loop-helix), forkhead, bZIP and HMG (high-mobility group) box. Many of these factors are known to be involved in tissue development or have been associated with cancer. A sub sequent validation assay showed that some of these TFs indeed bind to methylated DNA in vivo and regulate gene expression 53 . DNA microarray. DNA (or protein-binding) micro array technology has been used to determine the binding specificity of TFs 54, 55 . A double-stranded DNA micro array, typically comprising 40,000 unique DNA sequences that cover all possible combinations of 8-10-nucleotide-long DNA sequences that could constitute a binding motif, is incubated with a purified TF so that its binding preference can be accurately determined. In a recent study, the bacterial DNMT SssI was used to methylate the CpG sites of the sequences on the array 56 , followed by individual probing with eight purified proteins containing bZIP domains. By comparing the binding profiles of each protein obtained on the methy lated and unmethylated microarrays, proteins that preferentially bind to specific sequences were determined. Among the eight bZIP proteins, CEBPα and CEBPβ were found to specifically bind to a methylated sequence 56 . This approach enables a large amount of DNA sequences to be surveyed for protein-DNA interactions; accurate sequence specificity can, therefore, be determined for a given protein. However, prior knowledge of a candidate TF Limited by antibody quality and availability
57,58
ChIP-BS-seq, chromatin immunoprecipitation followed by bisulfite sequencing; MS/MS, tandem mass spectrometry; TF, transcription factor.
is required because it can be cumbersome to survey an entire TF family. Therefore, this approach is ideally used for fine-mapping sequence specificity of a previously identified mCpG-binding protein.
ChIP-BS-seq.
To determine methylation-dependent protein-DNA interactions in vivo, chromatin immunoprecipitation followed by bisulfite sequencing (ChIP-BS-seq) is an ideal approach. ChIP is first performed to obtain the DNA sequences that are bound by a protein of interest, and then the methylation level is sequentially determined using BS-seq. This approach was developed recently to determine the crosstalk between histone modifications and DNA methylation [57] [58] [59] . However, it requires prior knowledge of mCpG-binding proteins and the availability of antibodies that are directed against the proteins of interest. For example, after KLF4 was determined to bind to mCpG sites, ChIP-bisulfite conversion followed by PCR was used to validate the methylated DNA-protein interactions in vivo 53 . It is important to note that ChIP-BS-seq is the only approach that does not use naked DNA fragments to identify the TFs that bind to methylated DNA. Therefore, TFs identified using the other methods may not necessarily recognize mCpGs in vivo, and further studies are needed to dissect the functionality of the interactions.
Methylated DNA-TF interactions in vivo
Several studies have demonstrated that methylated DNA-TF interactions can occur in a cellular context (in vivo). For example, ZFP57 and its cofactor KAP1 were shown to bind selectively to nine DNA-methylated alleles of imprinting control regions (ICRs) in ES cells 43 . In another study, ZFP57 binding sites were mapped in hybrid ES cells, and ZFP57 was found to interact with the methylated parental-origin allele 60 . Similarly, Kaiso was shown to bind to the methylated promoter of the MTA2 gene in HeLa cells 61 . Another study, which used a quantitative ChIP-PCR assay, demonstrated that Kaiso binds to the methylated promoters of CDKN2A, MGMT and HIC1 in both HCT116 and Colo320 human colon cancer cell lines 62 . The finding that Kaiso binds to the methylated promoter of CDKN2A was recently reproduced in an independent study 63 . By contrast, a different study discovered that Kaiso was not associated with highly methylated promoters in GM12878 lymphoblastoid cells or in K562 human myeloid leukaemia cell lines 64 . Of note, this observation does not necessarily rule out the possibility that Kaiso binds to methylated DNA motifs in other cell types; rather, it suggests that methylation-dependent TF-DNA interactions may be cell type-specific. That is, some TFs might bind to methylated DNA motifs in certain cell types but not in others, presumably owing to variations in accessibility to methylated motifs in different cell types and/or dynamics of the DNA methylomes during differentiation and development.
Although these studies may suggest that some TFs can bind to methy lated DNA in vivo, one important question remains: how prevalent are methylated-DNA-TF interactions in a given genome? For example, the studies showing that Kaiso binds to methylated DNA in vivo [58] [59] [60] were focused on a few genes or genomic regions rather than genome-wide surveys. To determine to what extent these TFs interact with methylated loci in cells, we globally evaluated the accessibility of highly methylated regions in the H1 human ES cell line. Integration of the DNA accessibility data obtained by mapping DNase I hypersensitivity sites (DHSs) 65 and the DNA methylome data obtained from the same cell type 28 revealed that numerous open chromatin regions (that is, accessible regions) indeed contain highly methylated CpG sites. Overall, 258,188 DHS peaks were determined in the H1 human ES cell line by The ENCODE Consortium. By superimposing the DHS peaks with the DNA methylome of the H1 cells determined by whole-genome BS-seq 28 , we calculated the average methylation level (m) of CpG sites within a DHS peak, defined as:
where N is the number of CpG sites within a peak, and m i is the methylation level for CpG site i. Overall, 77,124 (29.9%) of the 258,188 DHSs detected in H1 cells had an average methylation level greater than 80% at CpG sites (FIG. 2a) , suggesting that many methylated CpG sites are accessible to TFs.
We then examined whether the TFs listed in TABLE 2 could interact with methylated DNA in vivo. We obtained TF ChIP-seq data sets in H1 ES cells from The ENCODE Consortium, and uniform peaks were called using the Irreproducible Discovery Rate (IDR) method 66 . The ChIP-seq peaks were superimposed with the methylome data set and the average methylation levels within each ChIP-seq peak were calculated using the method described above. For each TF, we obtained the distribution of the methylation level for each ChIPseq peak. Although the availability of ChIP-seq data sets was limited, six TFs (namely CEBPβ, E2F6, BACH1, RFX5, KLF4 (REF. 28 ) and retinoic acid receptor RXRα) had ChIP-seq data in H1 cells (TABLE 2) . The DNA methylation levels within the ChIP-seq peaks showed a bimodal distribution for all TFs except RXRα, indicating that a substantial fraction of their binding sites are located in highly methylated regions (FIG. 2a) . For example, of the 15,557 ChIP-seq peaks identified for CEBPβ, 6,675 (42.9%) had a methylation level greater than 80%. As a comparison, we selected two TFs (nuclear respiratory factor 1 (NRF1) and transcription initiation factor TFIID subunit 1 (TAF1)), which are known not to interact with methylated DNA (based on our current knowledge), as negative controls: neither NRF1 (FIG. 2a) nor TAF1 (Supplementary information S1 (figure)) showed a bimodal distribution, demonstrating that these TFs only bind to regions with low levels of methylation.
We further examined whether the methylated CpG sites located exactly at the TF binding sites (~10-20 bp) within the ChIP-seq peaks (200-500 bp), using CEBPβ as an example (FIG. 2b) . We first used the MEME (multiple EM for motif elicitation) algorithm to predict significantly enriched sequence motifs using the sequences of 28 (see also Further Information) or with DNA accessibility data 65 obtained from mapping DNase I hypersensitivity sites (DHSs) from the same cell lines suggests that some TFs bind to methylated DNA in vivo. All of the data, including DHS, ChIP-seq and DNA methylome, were obtained from the H1 embryonic stem cell line. The x axis shows the average methylation level (percentage) of the CpG sites within a DHS or TF ChIP-seq peak, and the y axis shows the fraction of peaks with a certain average methylation level. The methylation levels within each DHS peak show bimodal distribution, indicating that a large portion of highly methylated CpGs (mCpGs) are accessible to TFs. The methylation levels within the ChIP-seq peaks for five TFs (namely CCAAT/ enhancer-binding protein-β (CEBPβ), E2F6, Krüppel-like factor 4 (KLF4), RFX5 and BACH1) also show a bimodal distribution, suggesting that they can interact with methylated DNA in vivo. Retinoic acid receptor RXRα shows no binding activity in highly methylated regions, similar to the negative control nuclear respiratory factor 1 (NRF1). b | We examined whether methylation occurred in the binding sites within the ChIP-seq binding peaks. DNA sequences within each ChIP-seq peak were extracted and grouped based on their average methylation level. The low methylation group contains peaks with a methylation level of <60% and the high methylation group contains peaks with a methylation level of >80%. MEME (multiple EM for motif elicitation) analysis was performed on each of the top 500 peaks with the highest ChIP-seq intensities for the two groups and the most significant motifs were identified. The motif was then used to scan the DNA sequence within each peak and the DNA segment with highest match score to the motif was recorded. The methylation level was examined for the CpG sites within the identified DNA segment. As illustrated with CEBPβ, a matched segment (for example, 5′-GTTGCGTAAT) containing a highly methylated CpG site in the middle was identified within a ChIP-seq peak. c | Motifs were identified separately for binding peaks with low-level (<60%) methylation and high-level (>80%) methylation. To obtain the most reliable methylated motifs, the DNA sequences that match to the MEME motif were further grouped based on the position of the mCpG, and the sequences with a methylation level of >80% were assembled to generate the methylated motif for each subgroup. The mCpG sites for each subgroup are outlined with red boxes.
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Highly methylated motif
the ChIP-seq peaks that have a low methylation level 67 . The most significantly enriched motif did not contain a CpG site. Interestingly, when the same analysis was applied to those peaks that have high methylation levels, a significantly enriched motif containing a CpG site at position 4 was discovered (FIG. 2b) . We next examined the methylation level of the CpG sites within the motif in each ChIP-seq peak (FIG. 2b) . Among the 6,675 peaks with a high methylation level, 3,894 carried a highly methylated (>80%) CpG site within the enriched motifs. A motif could be reconstructed with these 3,894 binding peaks, which represented the methy lated motif for CEBPβ (FIG. 2c) . The same analysis was performed for the other four TFs. In summary, 25.0% (3,894 out of 15,557), 7.7% (1,103 out of 14,396), 5.2% (88 out of 1,695), 3.0% (115 out of 3,793) and 1.6% (186 out of 11,457) of binding sites were highly methylated for CEBPβ, E2F6, RFX5, KLF4 and BACH1, respectively (FIG. 2c) . Note that this is a conservative estimate because we used a stringent definition of highly methylated sites (that is, >80%).
Taken together, the above analysis suggests that many TFs shown to bind methylated DNA in vitro are also able to interact with methylated DNA in vivo, although further in vivo genome-wide characterization of TF binding patterns and high-resolution DNA methylation analyses are needed to strengthen the evidence base. The list of TFs that interact with methylated DNA (TABLE 2) provides a foundation for further functional characterization of methylated DNA-TF interactions in various biological processes.
Features of methylated-DNA-protein interaction
Protein domains that interact with methylated DNA. Identification of the protein domains that recognize mCpG sites is important to characterize mCpGdependent protein-DNA interactions. Such knowledge will enable the mutation of critical residues within these domains that abolish the mCpG-dependent binding activity of these proteins, while maintaining their ability to bind non-methylated DNA. Therefore, mutated proteins can be useful tools to dissect the physiological roles of mCpG-dependent protein-DNA interactions.
Besides the well-known MBDs, other protein domains seem to interact with mCpG sites. For example, the recent crystal structure of mouse ZFP57 in complex with a methylated DNA sequence demonstrated that its two zinc-fingers interact with methylated DNA, and that an arginine (Arg178), which is involved in hydrophobic interactions, plays a crucial part in mCpG binding 44 . A separate study suggested that an arginine and glutamate pair in KLF4 recognizes the mCpG site 68 . A structural comparison of MeCP2 and KLF4 indeed showed a common structural feature involving one arginine and one asparagine 53 . A global survey of methylated-DNA-binding proteins suggests that many other protein domains might also be able to interact with mCpG sites, including homeobox, HLH and E2F domains 53 . There are currently no general rules of evolutionary conservation for the domains that interact with methylated sites, owing to a lack of data from multiple species.
However, in a comparison of mCpG-binding proteins between humans and mice 51, 53 , a few proteins such as KLF4 and homeobox A5 (HOXA5) were shown to bind mCpG sites in both species, which is indicative of the functional importance of methylation-dependent protein-DNA interactions.
Sequence specificity. Notably, many proteins can bind both non-methylated and methylated sequences in a different sequence context. For example, CEBPα is known to bind a particular sequence element, 5′-TGACGTCA 42 . However, when the CpG is methylated, CEBPα can effectively recognize half of the motif: 5′-mCGTCA 42 . Similarly, although KLF4 recognizes a non-methylated canonical motif of 5′-TTTACGCC, it has been demonstrated that KLF4 specifically recognizes a 5′-TCCmCGCCC motif only when the CpG is methylated 53 . If the methylation status of these two sequences is exchanged, KLF4 loses the ability to bind to either sequence 53 . Indeed, for many newly discovered methylated DNA-binding proteins, the methylated motifs differ from the non-methylated motifs 53 . Therefore, it is reasonable to speculate that 5mC might represent the fifth nucleotide that further fine-tunes the specificity of protein-DNA interactions; that is, 5mC acts as an additional regulatory layer to remove, create and/or change TF binding sites (FIG. 1) .
Several recent studies have started to provide the structural basis for the altered sequence specificity due to DNA methylation. Both in vitro DNase I digestion assays and structural studies indicate that methylation has a profound impact on DNA structure and shape (for an in-depth review see REF. 69 ). Adding a methyl group to the cytosine could affect the local DNA shape, as evidenced by the altered DNase I digestion rate and patterns 70, 71 . Similarly, based on a few reported crystal structures of double-stranded DNA fragments with 5mC bases 68, 72, 73 , the presence of a bulky methyl group in the major groove leads to a subtle widening of the major groove and a subtle narrowing of the minor groove. Consequently, 5mC can affect the access of a given TF to the affected motifs in both major and minor grooves in genomic DNA and thus change the sequence specificity of protein-DNA interactions.
Binding affinity. One important question is whether methylated-DNA-protein interactions have a similar binding affinity to the interactions between the same protein and a non-methylated DNA, or whether they are just labile interactions. Using an in vitro pulldowncoupled MS/MS approach, the relative affinity of protein-mCpG interactions can be estimated 51 . For example, for a particular sequence (5′-GGGCGTG), which was determined on the basis of the KLF4 ChIPseq data sets 74 , KLF4 showed higher affinity when the cytosine in the motif was methylated compared with the unmethylated sequence 51 . The protein microarray approach 53 , which uses the concept of relative affinity to identify proteins that preferentially bind to methylated DNA, revealed proteins with strong fluorescent signals, which are expected to bind tighter to the
The dissociation constant K d is defined by the K off /K on ratio, which has the unit of concentration. 
Oblique incidence reflectivity difference (OIRD)
TETs
(Ten-eleven translocation proteins). The TET family of methylcytosine dioxygenases is made of TET1, TET2, TET3 and TET4, which catalyse the conversion of the modified DNA base 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC).
methy lated motif than to the unmethylated counterpart. The absolute binding affinity (that is, K d values) can be measured by applying the oblique incidence reflectivity difference (OIRD), which is a real-time, label-free method to measure the kinetics of a binding event 53, 75 . Three proteins (ZMYM3, AP2α and KLF4) were selected to determine the K on and K off values with their corresponding motifs in methylated forms. The deduced K d values of ZMYM3, AP2α and KLF4 were determined as 460 nM, 399 nM and 479 nM, respectively. Importantly, no obvious affinity could be detected when these tested motifs were unmethylated. As a comparison, the K d values of the short isoform of MBD2, MBD2b, for the same motifs ranged from 97 nM to 197 nM, suggesting that MBD-lacking TFs bind to methylated DNA motifs nearly as strongly as MBD2b.
Cis-regulatory elements. To better understand the physio logical role of mCpG-binding proteins, it is important to determine which methylated regions in the genome can be specifically recognized by these proteins. Although MBD family proteins tend to bind to regions with a high methylation density (that is, high methylation level and high CpG density) 76 , it is interesting to examine whether the same is true for sequence-specific mCpG-binding proteins.
As protein-DNA interactions are dynamic, differentially methylated regions might be possible candidates for methylation-dependent interactions. Analysis of the methylomes obtained from 17 adult mouse tissues at single base-pair resolution showed that approximately 6.7% of the mouse genome is differentially methylated, mostly at distal cis-regulatory regions 77 . Another study discovered that regions with a low level of methylation, ranging from 10% to 50%, often occur at distal regulatory regions 78 ; that is, regions that are enriched for enhancer marks, including high levels of histone H3 lysine 4 monomethylation (H3K4me1) as well as binding sites for p300 histone acetyltransferase and other regulatory factors. Similarly, extensive DNA methylation was found to coexist with active H3K27 acetylation (H3K27ac) marks in a large number of enhancers 79 . More importantly, the reduction of DNA methylation led to a decrease in H3K27ac marks, suggesting an active role of DNA methylation in regulating enhancer activity. Based on the analysis of KLF4 binding in ES cells, we also found that KLF4 binds to methylated enhancer regions 53 , which may suggest that sequence-specific mCpG-binding proteins interact preferentially with distal enhancer regions.
Cause or consequence? Although many proteins have been found to recognize methylated DNA, the causality between DNA methylation and TF binding is far from clear. On the one hand, DNA methylation could dictate the interaction between proteins and DNA, but on the other hand, the binding of certain proteins may affect the methylation of DNA. Recent studies suggest that both scenarios can occur in different contexts (FIG. 3) .
Protein binding affects the DNA methylation status.
The binding of methyltransferases or methylcytosine dioxygenases (for example, DNMTs and TETs (teneleven translocation proteins)) affects the status of DNA methylation, but recent studies suggest that many non-enzymatic proteins, such as TFs, could regulate the establishment and maintenance of the local DNA methy lation levels in a sequence-specific fashion. One such regulator is the transcriptional repressor CTCF, which is known to have an essential role in imprinting control; that is, to achieve allele-specific gene regulation 80 . CTCF binds to the unmethylated ICRs in maternal alleles, which prevents distal enhancers from activating downstream genes 81 . By contrast, when the paternal ICR is methylated, CTCF cannot bind to the ICR, thus allowing the activation of downstream genes by distal enhancers. One study suggests that CTCF itself contributes to the maintenance of the non-methylated status of maternal ICRs, as maternally transmitted mutant ICRs in neonatal mice that harbour point mutations in CTCF binding sites acquire a hetero geneous degree of methylation 82 . Although the traditional view of imprinting control is that differential methylation leads to differential binding of CTCF, and thus yields allele-specific gene regulation, this study suggests that CTCF binding itself is necessary to maintain differential methylation of ICRs.
Moreover, a recent report confirmed that the binding of some proteins (for example, CTCF and RE1-silencing transcription factor (REST)) can affect local methylation patterns 78 . The authors first created a reporter construct with a CTCF-binding motif that was inserted into a genomic locus in mouse ES cells. Insertion of the binding site induced CTCF binding and resulted in a reduced methylation level in local genomic regions. A single-nucleotide mutation in the CTCF binding motif had no effect on the DNA methylation level. To test the effect in an endogenous setting, the authors generated a Rest −/− mouse ES cell line and, as expected, observed that the REST binding regions were highly methylated. Most importantly, they found that the methylation levels at these sites were much reduced after reintroduction of wild-type Rest into the cells. Altogether, these results support a model whereby the binding of certain proteins can directly affect DNA methylation levels (FIG. 3) .
Another study examined the methylation levels of hundreds of sequences that were individually inserted at the same genomic site in mouse ES cells 83 . Using this approach, the contribution of various sequence motifs to methylation levels could be quantified. They found that CpG density showed a negative correlation with methylation level, which is consistent with the previously established view that CpG islands are generally unmethylated. Interestingly, when the sequences of binding motifs were altered, overall methylation levels decreased 83 . This work suggests that protein binding has a general role in reducing DNA methylation levels, perhaps by preventing DNMT enzymes from gaining access to these sites, which is consistent with previous findings 84 .
As TFs have no enzymatic activity to methylate or demethylate a CpG dinucleotide, a possible model would be that these proteins provide sequence-specific guidance and recruit methyltransferases or methylcytosine dioxy genases to these specific sites (FIG. 3) . A recent study showed that the nuclear receptor PPARγ (peroxisome proliferator-activated receptor-γ) recruits TET1, resulting in a reduced methylation level around its binding sites through the interaction with TET1 (REF. 85 ). The reverse can also happen. DNMTs have been found to form protein complexes with various TFs or chromatin modification enzymes. For instance, Sato et al. 86 demonstrated that DNMT3A and DNMT3B interact with an orphan nuclear receptor, NR6A1 (nuclear receptor subfamily 6 group A member 1), and that this interaction induced the methylation of the OCT4 (also known as OCT3 and POU5F1) promoter carrying the NR6A1 binding site.
DNA methylation dictates protein-DNA interactions.
It is well known that DNA methylation can affect the binding of some TFs 87 . The manipulation of the methylation status of DNA sequences has been shown (mostly in in vitro studies) to result in the differential binding of TFs, including E2F, AP2α, MYC and MYN [88] [89] [90] [91] [92] [93] [94] [95] . Specifically, hypermethylation is often associated with a depletion of TF binding. Recently, a few studies examined the effect of DNA methylation on TF binding in vivo 96, 97 . Using a gene-editing approach, Domcke et al. 97 generated a genetic deletion of three methyltransferases (Dnmt3a, Dnmt3b and Dnmt1) in a mouse ES cell line. A large number of novel binding sites for the TF NRF1 were created as a result of the triple knockout (TKO). These binding sites often correlated with novel DHSs in the TKO cells, which exhibited predominantly low methylation levels due to their generation in cells lacking DNMTs. Interestingly, novel NRF1 binding sites were hypermethylated in the wild-type cell line 97 , suggesting that the removal of DNA methylation in TKO cells generated new binding sites for NRF1. These new binding sites had poor sequence conservation, indicating that these sites are non-functional in the wild-type background. In an earlier study, the same group showed that CTCF was able to reduce the DNA methylation level near its binding sites 78 . In this work, the authors tested whether CTCF binding could affect NRF1 binding by reducing the methy lation level of NRF1 binding sites. Reporter constructs harbouring an NRF1 binding motif and a CTCF motif were introduced into the ES cell line. Deletion of CTCF motifs within the construct led to hypermethylation and thus decreased NRF1 binding, suggesting that NRF1 binding in vivo depends on both methylation levels and co-occurring TFs, such as CTCF 97 . The examples above represent the two major mechanisms by which protein-DNA interactions and DNA methylation influence each other (FIG. 3) . Of note, these two mechanisms are not mutually exclusive. In some cases, the two mechanisms have been found to coexist for the same TFs. For example, although CTCF is known to change the local methylation status 78 , it has been shown that the binding of CTCF is also methylation sensitive 96 . Finally, it is worth noting that the crosstalk between TF-DNA interaction and DNA methylation is not restricted to the TFs whose binding motifs contain CpGs. Changes in DNA methylation are often associated with chromatin status, resulting in increased or decreased DNA accessibility 96, 97 . Differences in chromatin states will either create or eliminate TF binding sites and thus lead to differential TF binding. Although only approximately 25% of known TF binding motifs contain at least one CpG site 98 , through such indirect crosstalk mechanisms, the binding of TFs without CpGs in their binding motifs could also be influenced by DNA methylation.
Biological consequences
Activation or repression. Methylation in promoters is often considered the hallmark for gene repression 99 . However, large-scale analyses of gene expression profiles and DNA methylomes have revealed that a substantial proportion of DNA methylation sites is positively correlated with gene expression 31 . This analysis was performed on methylation sites located within 300 bp upstream from transcriptional start sites, which raises the possibility that methylation in promoters could also be positively correlated with increased transcription of a target gene 31 (FIG. 4) . Of course, whether these methylation sites fall exactly within the regulatory elements and whether they are recognized by TFs remains to be tested. Single-gene studies have also demonstrated that DNA methylation can activate gene expression [47] [48] [49] . For example, the sequence-specific DNA-binding protein RFX activates a methylated promoter 49 . Interestingly, this protein was previously shown to bind to methylated DNA 47, 51 . Moreover, it was found that methylation at the 3′ end of the CpG island confers tissue-specific transcriptional activation during human ES cell differentiation 100 . A recent comparative study of mouse retina and brain explicitly explored the possible role of methylation sites whose methylation levels were positively correlated with gene expression 101 . Among the differentially methylated regions located within 4 kb upstream of transcriptional start sites, approximately 47% showed a positive correlation with the expression of their putative target genes. These methylation regions are overrepresented in DHSs and are evolutionarily conserved, suggesting that these sites are likely to be functional 101 . More importantly, a distinct set of sequence motifs was discovered in these regions, suggesting that some TFs bind preferentially to these regions 101 .
Pioneer TFs. The human genome is not made of linear, naked DNA strands. Instead, it is mainly organized into two forms. One is heterochromatin (or condensed chromatin), in which DNA sequences and histones are highly condensed, and genes in these regions are inactive. The other form is euchromatin (or open chromatin), in which DNA sequences are largely accessible to TFs, and genes in these regions can be activated 102, 103 . Chromatin organization is dynamic, and the different types of chromatin can change from one form to another during development or differentiation 104 (FIG. 4) .
Pioneer TFs are a unique subset of TFs that drive these chromatin changes. A typical characteristic of pioneer TFs is their ability to bind directly to heterochromatic DNA and recruit other factors to change the status to euchromatin to initiate transcription 105, 106 . As DNA in heterochromatin is wrapped tightly around the nucleosomes and is often methylated, it is inaccessible to most TFs; pioneer TFs must possess special features to enable protein-DNA interactions. For example, a handful pioneer TFs (such as OCT4, SOX2 and KLF4) were shown to bind only partial motifs displayed on the nucleosome surface 107 . It could be speculated that the ability to bind mCpG sites might prove a useful property for pioneer TFs. If a pioneer TF can interact with an mCpG site, such an interaction would provide an anchor point for the pioneer TF to open up the closed chromatin. Indeed, we observed a large overlap between known pioneer TFs and proteins that bind to methylated DNA (for example, forkhead box protein A (FOXA) and GATA families, which are the best-studied pioneer factors) 106, [108] [109] [110] . Interestingly, several of their members showed the ability to bind to methylated DNA, including HOXA5, HOXA9, GATA3 and GATA4 (REF. 53 ). The mCpG-binding protein KLF4 was also shown to be a pioneer factor 105, 111 . Although there is no simple assay to identify pioneer TFs, evidence that TFs are able to bind methylated DNA would provide a short list of candidate pioneer TFs for future tests. Notably, as methylation-binding proteins participate in multiple biological processes, including gene regulation and splicing regulation, not all methylation-binding proteins are likely to be pioneer factors. Yet, binding to an mCpG site is just one approach for a pioneer TF to access condensed chromatin. Other pioneer TFs might have alternative approaches such as binding to partial motifs.
Splicing regulation. Historically, RNA splicing was considered to be regulated only at the post-transcriptional level. On the basis of this idea, DNA methylation was not expected to have any substantial role in splicing regulation. However, it is now well-established that splicing occurs co-transcriptionally, which means that DNA modification could influence RNA splicing. In one study, the authors observed that the binding of CTCF in an exon region created a roadblock for RNA polymerase II elongation and thus promoted the inclusion of the exon 112 . Importantly, the binding of CTCF to the exon or intron was dependent on DNA methylation, suggesting that the methylation status surrounding the spliced exons could affect the inclusion level of these exons. Similarly, the mCpG-binding protein MeCP2 was found to play a part in regulating exon splicing 113 . In this case, a high methylation level led to MeCP2 binding to alternatively spliced exons, which resulted in exon inclusion (FIG. 4) . The same trend was observed in a study of the brain methylome of honeybees 114 . A comparison of methylation levels between queen and worker bees revealed that intron-containing histone genes were highly methylated, whereas intronless histone genes were not methylated, suggesting that mCpG-binding proteins might play a part in splicing regulation. This observation is consistent with a global correlation analysis of DNA methylation and differential splicing events between the brain and the retina 115 . Although CTCF motifs were significantly enriched in differentially methylated regions associated with alternative splicing, other motifs were also enriched, suggesting that other TFs might also participate in splicing regulation. Interestingly, the methylation levels in some of the regions were positively associated with the inclusion level of the spliced exons, indicating that other mCpG-binding proteins are involved in regulating the splicing process.
Human diseases.
Many studies have shown that aberrant DNA methylation is associated with various human diseases, including some types of cancer [19] [20] [21] . For example, profiling the DNA methylation status in the promoters of 272 glioblastoma tumours showed that a distinct subset of samples displayed hypermethylation at a large number of loci, a phenotype termed 'CpG island methylator phenotype' (REF. 116 ). However, the mechanism by which the altered epigenetic state causes disease remains elusive. A recent study analysed the effect of methylation-dependent protein-DNA interactions on gliomas 117 . The IDH genes (IDH1 and IDH2) encode isocitrate dehydrogenases, and mutations in these genes are among the most frequent found in diffuse gliomas 118, 119 . Mutant IDH protein is a competitive inhibitor of hydroxylases, including the TET family of 5mC hydroxylases [120] [121] [122] . As a result, the IDH mutation leads to a remodelling of DNA methylation profiles. Specifically, owing to the interference with TET family proteins, the mutation causes the CpG island methylator phenotype 116, 123 . IDH mutant gliomas have been shown to exhibit hypermethylation at CTCF binding sites, which leads to a reduction in CTCF binding; loss of CTCF in topologically associated domains removed the domain boundary and caused aberrant gene activation 117 .
Conclusions
Similar to genome-wide association studies (GWAS), the profiling of epigenomes (including DNA methylomes) has been extensively carried out under various physiological conditions and in many different biological systems. Transitioning to a post-epigenome era, it is time to elucidate the functional consequences of the observed changes in DNA methylation status and link these changes to phenotypes. Although the role of MBD proteins, as non-sequence-specific methylation readers, has been fairly well-studied, the biological functions of an emerging class of sequence-specific methylation readers and/or effectors remain elusive.
To fully understand the biological processes that are mediated by DNA methylation, many challenges and unanswered questions regarding the methylation readers and/or effectors remain to be tackled in future research. First, we need a more comprehensive catalogue of methy lation readers and effectors. Although a few studies have provided more than 100 proteins that can interact with methylated DNA in humans and mice, more readers remain to be discovered in these and other species. An evolutionary conservation analysis of these proteins will provide critical insights into their functional importance. In addition, the identification of the readers for 5mC derivatives (BOX 1) will greatly facilitate the elucidation of their roles in epigenetics. Second, these newly identified methylation readers require more and detailed characterization. For example, it is imperative to understand whether these TFs actually interact with genomic DNA in vivo. As we demonstrated above, superimposing ChIP-seq and DNA methylome data sets can be an effective approach to validate mCpG-dependent DNA-TF interactions in vivo. Although more technically challenging, ChIP-coupled genome-wide BS-seq is a more direct approach to map the in vivo protein-mCpG interactions. Another possible approach is to observe genome-wide changes in TF binding sites by perturbing DNA methylation; for example, by knocking out DNMTs or by pharmacologically removing DNA methylation. Finally, the physiological relevance of protein-mCpG interactions will need to be established. Given a lack of adequate assays or approaches, this could well be a daunting task. A methylation reader usually interacts with both methylated sites and unmethylated sites. Therefore, simply knocking down a methylation reader will not help reveal its role. Identification of the key residues that interact with mCpG sites and the effects of mutations of these residues will provide the next step to dissect the functional role of methylation readers.
Taken together, the notion that TFs may act as DNA methylation readers is an emerging concept supported by predominantly in vitro but also by emerging in vivo evidence. Of note, this new concept does not refute the conventional view that most TFs do not interact with methylated DNA. Instead, these two scenarios may well coexist in cells. Here, we have focused on this exciting and novel concept with a full awareness that it may apply only to a subset of TFs and to a subset of their binding sites.
